Sanofi/$SNY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sanofi
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Ticker
$SNY
Sector
Primary listing
Employees
74,846
Headquarters
Website
Sanofi Metrics
BasicAdvanced
$105bn
6.04
$7.23
0.28
$1.60
3.66%
Price and volume
Market cap
$105bn
Beta
0.28
52-week high
$52.68
52-week low
$42.33
Average daily volume
2.7m
Dividend rate
$1.60
Financial strength
Current ratio
1.005
Quick ratio
0.201
Long term debt to equity
18.922
Total debt to equity
27.372
Dividend payout ratio (TTM)
63.16%
Interest coverage (TTM)
18.84%
Profitability
EBITDA (TTM)
14,955.769
Gross margin (TTM)
72.36%
Net profit margin (TTM)
15.95%
Operating margin (TTM)
20.49%
Effective tax rate (TTM)
16.83%
Revenue per employee (TTM)
$734,550
Management effectiveness
Return on assets (TTM)
4.67%
Return on equity (TTM)
6.58%
Valuation
Price to earnings (TTM)
6.039
Price to revenue (TTM)
0.959
Price to book
1.25
Price to tangible book (TTM)
24.36
Price to free cash flow (TTM)
6.679
Free cash flow yield (TTM)
14.97%
Free cash flow per share (TTM)
6.538
Dividend yield (TTM)
3.66%
Forward dividend yield
3.66%
Growth
Revenue change (TTM)
4.84%
Earnings per share change (TTM)
22.95%
3-year revenue growth (CAGR)
0.83%
10-year revenue growth (CAGR)
3.20%
3-year earnings per share growth (CAGR)
-2.29%
10-year earnings per share growth (CAGR)
6.48%
What the Analysts think about Sanofi
Analyst ratings (Buy, Hold, Sell) for Sanofi stock.
Sanofi Financial Performance
Revenues and expenses
Sanofi Earnings Performance
Company profitability
Sanofi News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs